EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
2,713,768
Share change
-1,527,879
Total reported value
$27,083,000
Price per share
$9.98
Number of holders
14
Value change
-$15,191,173
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q4 2021

As of 31 Dec 2021, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,713,768 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, Magnetar Financial LLC, Verition Fund Management LLC, Sio Capital Management, LLC, Wealthspring Capital LLC, Sage Mountain Advisors LLC, Schechter Investment Advisors, LLC, TD ASSET MANAGEMENT INC, and HRT FINANCIAL LP. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.